"Insurers were going to cover Zolgensma no matter the price," says Dr. Steven D. Pearson, president of the nonprofit Institute for Clinical and Economic Review in Boston, an independent research group that studies drug pricing. "It is a positive outcome for patients and the entire health system that Novartis instead chose to price Zolgensma at a level that more fairly aligns with the benefits for these children and their families."
The fight in Russia was a rare three-round main event because it was a rescheduled three-rounder from three weeks ago, a move made after Magomedsharipov had to pull out with a staph infection. He and Kattar originally were scheduled to meet in Boston, 30 miles from Kattar's Massachusetts hometown, but the fight was postponed until this weekend and moved 4,466 miles to CSKA Arena in Moscow. That's a good 1,000 miles from Magomedsharipov's home in Dagestan, but it still played out like a home game for him.
Cofactor is a large, structured listing of people, places, and things. Here you can find the description of each topic.